Clinical trial
Tenofovir/Emtricitabine for PMTCT in Africa and Asia (ANRS 12109 TEmAA)
NCT00334256 · French National Agency for Research on AIDS and Viral Hepatitis, Other · Completed
Key facts
| NCT number | NCT00334256 |
|---|---|
| Title | Tenofovir/Emtricitabine for PMTCT in Africa and Asia (ANRS 12109 TEmAA) |
| Official title | Phase II Trial, Multicentre, Opened Label Evaluating the Pharmacokinetics and the Safety and Toxicity of the Tenofovir-Emtricitabine Combination in Pregnant Women and Infants in Africa and Asia |
| Acronym | TEmAA |
| Lead sponsor | French National Agency for Research on AIDS and Viral Hepatitis, Other |
| Collaborators | European and Developing Countries Clinical Trials Partnership (EDCTP) Gilead Sciences Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infection, Pregnancy |
| Intervention type | Drug |
| Interventions | Tenofovir (TDF), Emtricitabine (FTC) |
| Enrollment | 72 |
| Start date | Oct 1, 2006 |
| Primary completion | Jul 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | Jun 7, 2006 |
| Last update posted | Dec 5, 2011 |
| Countries | Cambodia, Côte d’Ivoire, South Africa |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: